Lin, L., van der Meer, E. K. O., Steeghs, N., Beijnen, J. H., & Huitema, A. D. R. (2024). Are novel oral oncolytics underdosed in obese patients? Cancer Chemotherapy and Pharmacology, 93(2), 129-136. https://doi.org/10.1007/s00280-023-04601-z
Chicago-referens (17:e uppl.)Lin, Lishi, Ellen K. O. van der Meer, Neeltje Steeghs, Jos H. Beijnen, och Alwin D. R. Huitema. "Are Novel Oral Oncolytics Underdosed in Obese Patients?" Cancer Chemotherapy and Pharmacology 93, no. 2 (2024): 129-136. https://doi.org/10.1007/s00280-023-04601-z.
MLA-referens (9:e uppl.)Lin, Lishi, et al. "Are Novel Oral Oncolytics Underdosed in Obese Patients?" Cancer Chemotherapy and Pharmacology, vol. 93, no. 2, 2024, pp. 129-136, https://doi.org/10.1007/s00280-023-04601-z.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
